Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Older people who begin to feel lonely experience an accelerated decline in cognitive function compared…
Four years after winning FDA approval for Overity to treat major depressive disorder (MDD), Axum…
Heart drug developer Esperion to go private in potential $1.1 billion acquisition by ArchiMed
By healthadmin
Shortly after paying $75 million up front for Corstasis Therapeutics and its congestive heart failure…
Researchers at the University of Oxford have demonstrated a new type of quantum interaction using…
New study reveals significant gap between sexual pleasure and overall satisfaction in the US
By healthadmin
A recent study assessing sexual well-being in the United States suggests that while many people…
A team of scientists from King’s College London has identified a new form of aluminum,…
Get the health information and medications you need every weekday with STAT’s free newsletter Morning…
This is a pivotal year for Ionis Pharmaceuticals, a pioneer in RNA therapeutics. After moving…
Fierce Pharma Asia—Sun acquires organic compounds for $11.75 billion. Astellas Xtandy Peak. BeOne’s PD-1xVEGF Bet
By healthadmin
Sun Pharma will acquire Organon for $11.75 billion. Astellas Pharma predicts that sales of Xtandy…
The pharmaceutical sector faces patent cliffs and rising costs. Explore 2026 trends in AI drug discovery, gene therapy, biopharma manufacturing, clinical pipelines, and FDA approvals to drive efficiency and innovation.